| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.6M | +8.9% | +51.1% |
| SG&A Expense | $2.2M | +33.9% | +72.8% |
| Operating Income | -$7.8M | -15.1% | -56.7% |
| Pre-tax Income | -$7.8M | — | -57.2% |
| Income Tax | $2K | — | +0.0% |
| Net Income | -$7.8M | -16.2% | -57.2% |
| EPS (Basic) | -$0.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.3M | -29.3% | — |
| Current Assets | $5.9M | -28.3% | +42.4% |
| Total Assets | $13.0M | -8.4% | +47.9% |
| Current Liabilities | $4.0M | +97.3% | +225.1% |
| Total Liabilities | $4.2M | +80.6% | +126.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.8M | -100.7% | — |
| Capital Expenditures | $1.7M | +82.5% | — |
| Investing Cash Flow | -$1.7M | -82.5% | — |
| Financing Cash Flow | $4.7M | +542.4% | — |
| Free Cash Flow | -$12.5M | -98.0% | — |
| +0.0% |
| EPS (Diluted) | -$0.14 | -16.7% | +0.0% |
| $8.8M |
| -26.0% |
| +26.8% |